Teyi Pharmaceutical GroupLtd Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Teyi Pharmaceutical GroupLtd has a total shareholder equity of CN¥1.7B and total debt of CN¥640.0M, which brings its debt-to-equity ratio to 36.7%. Its total assets and total liabilities are CN¥2.5B and CN¥749.7M respectively. Teyi Pharmaceutical GroupLtd's EBIT is CN¥80.6M making its interest coverage ratio -17.2. It has cash and short-term investments of CN¥599.9M.
Belangrijke informatie
36.7%
Verhouding schuld/eigen vermogen
CN¥640.00m
Schuld
| Rente dekkingsratio | -17.2x |
| Contant | CN¥599.88m |
| Aandelen | CN¥1.74b |
| Totaal verplichtingen | CN¥749.68m |
| Totaal activa | CN¥2.49b |
Recente financiële gezondheidsupdates
Recent updates
We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt
Jun 06
Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems
Apr 26Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market
Mar 06Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching
Feb 27Analyse van de financiële positie
Kortlopende schulden: 002728's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥715.2M).
Langlopende schulden: 002728's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥34.5M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 002728's net debt to equity ratio (2.3%) is considered satisfactory.
Schuld verminderen: 002728's debt to equity ratio has reduced from 95.8% to 36.7% over the past 5 years.
Schuldendekking: 002728's debt is not well covered by operating cash flow (13.8%).
Rentedekking: 002728 earns more interest than it pays, so coverage of interest payments is not a concern.